Promega Corporation

SAM2™ Biotin Capture Membrane and SignaTECT™ Protein Kinase Assay Systems

  • Share
  • Print
  • Email
  • Download PDF
  • Article
  • Comments & Ratings

Abstract

Promega's SignaTECT™ Protein Kinase Assay Systems combine the use of biotinylated target peptide substrates with a unique Streptavidin Matrix Membrane to specifically and accurately quantitate the activity of protein kinases in a variety of samples. This technique provides low backgrounds and high signal-to-noise ratios even with complex samples such as crude cell extracts, while retaining the high capacity necessary to maintain optimum reaction kinetics.

Promega Notes 58, 22.

Said Goueli, Erik Schaefer and Allan Tereba

Promega Corporation
Publication Date: 1996

Download Article (252 KB)

  • Warning
  • It appears that you have Javascript disabled. Our website requires Javascript to function correctly. Please enable Javascript to experience our website.